Anderson, W. F., Human Gene Therapy 5:281-282, 1994. |
Liszewski et al., "The Complement System," in Fundamental Immunology3rd Ed., Paul, W. E., Ed. Raven Press, New York, 1993. |
Takeuchi et al., J. Virology 68(12):8001-8007, Dec. 1994. |
Albrecht et al., "Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59" Virology, 190:527-530, 1992. |
Albrecht and Fleckenstein, "New member of the multigene family of complement control proteins in Herpesvirus saimiri" J Virology, 66:3937-3940, 1992. |
Bartholomew et al., "Lysis of oncornaviruses by human serum" J Exp Med, 147:844-853, 1978. |
Bartholomew and Esser, "Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranes" Biochem, 19:2847-2853, 1980. |
Cooper et al., "Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway" J Exp Med, 144:970-984, 1976. |
Culver et al., "In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors" Science, 256:1550-1552, 1992. |
Galili et al., "Evolutionary relationship between the natural anti-Gal antibody and the Gal.alpha.1.fwdarw.3 Gal epitope in primates" Proc Natl Acad Sci, USA, 84:1369-1373, 1987. |
Isaacs et al., "Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence" Proc Natl Acad Sci, USA, 89:628-632, 1992. |
McNearney et al., "Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity" J Exp Med, 166:1525-1535, 1987. |
Neethling et al., "Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by .alpha.-galactosyl oligosaccharides" Transplantation, 57:959-963, 1994. |
Ram et al., "Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors" J Neurosurg, 79:400-407, 1993. |
Repik et al., "Differential host-dependent expression of .alpha.-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model" J Gen Virol, 75:1177-1181, 1994. |
Rother et al., "Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri" J Virol, 68:730-737, 1994. |
Welsh et al., "Human serum lyses RNA tumour viruses" Nature, 257:612-614, 1975. |
Welsh et al., "Inactivation and lysis of oncornaviruses by human serum" Virology, 74:432-440, 1976. |
Widner and Brundin, "Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis", Brain Res Rev, 13:287-324, 1988. |
Immunology, vol. 76, 1992, Rooney et al., "Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid" pp. 541-547. |
The Journal Of Immunology, vol. 151, 1993, Lehto et al., "Interactions of soluble CD59 with the terminal complement complexes" pp. 4941-4949. |